Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 158.20
Bid: 158.20
Ask: 161.00
Change: -1.40 (-0.88%)
Spread: 2.80 (1.77%)
Open: 161.00
High: 161.00
Low: 158.20
Prev. Close: 159.60
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post-Stabilisation Period Announcement

13 Dec 2017 17:50

RNS Number : 2927Z
Barclays Capital Securities Limited
13 December 2017
 

13 December 2017

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any jurisdiction in which such distribution would be unlawful.

Sabre Insurance Group plc

Pre-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 06 December 2017 Barclays Bank PLC ('Barclays') (Ben West; telephone: +44 20 7773 9531) hereby gives notice that as Stabilising Coordinator, the Stabilisation Manager named below undertook stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) and of the rules of the Financial Conduct Authority) in relation to the offer of the following securities, as set out below.

 

The securities:

Issuer:

Sabre Insurance Group plc

Aggregate nominal amount/Offering size:

125,000,000 Ordinary Shares (excluding the over-allotment option)

Description:

Ordinary Shares in Sabre Insurance Group plc with a nominal value of £0.001. ISIN: GB00BYWVDP49

Offer price:

230p

Stabilisation:

Stabilisation Manager:

Barclays Capital Securities Limited, 5 The North Colonnade, Canary Wharf, London, E14 4BB, United Kingdom

Stabilisation started on:

6th December 2017

Stabilisation last occurred on:

13th December 2017

Stabilisation transactions:

Although stabilisation bids were made, no stabilisation transactions were carried out

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order) or who are high net worth persons falling within Article 49 of the Order and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities to which this announcement relates which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement is only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAGGGBCPUPMGMW
Date   Source Headline
7th Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSFinal Results
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:23 pmRNSNotification of Results Announcement Date
24th Mar 20207:00 amRNSDelay of Full Year results announcement
20th Mar 20204:48 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 202012:07 pmRNSSecond Price Monitoring Extn
18th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 202010:45 amRNSDirector/PDMR Shareholding
9th Mar 202012:07 pmRNSSecond Price Monitoring Extn
9th Mar 202012:02 pmRNSPrice Monitoring Extension
28th Feb 202010:14 amRNSDirector Declaration
11th Feb 20203:07 pmRNSDirector/PDMR Shareholding
13th Jan 20201:53 pmRNSDirector/PDMR Shareholding
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
11th Dec 201911:41 amRNSDirector/PDMR Shareholding
22nd Nov 20198:50 amRNSHolding(s) in Company
12th Nov 20192:35 pmRNSDirector/PDMR Shareholding
6th Nov 20191:57 pmRNSHolding(s) in Company
22nd Oct 20194:55 pmRNSHolding(s) in Company
22nd Oct 20194:52 pmRNSHolding(s) in Company
15th Oct 201910:03 amRNSDirector/PDMR Shareholding
11th Oct 20193:12 pmRNSDirector/PDMR Shareholding
11th Oct 201910:58 amRNSDirector/PDMR Shareholding
10th Oct 20197:00 amRNSTrading Update
20th Sep 201911:14 amRNSDirector/PDMR Shareholding
11th Sep 201910:26 amRNSDirector/PDMR Shareholding
4th Sep 201910:57 amRNSHolding(s) in Company
13th Aug 201912:18 pmRNSDirector/PDMR Shareholding
9th Aug 201912:07 pmRNSSecond Price Monitoring Extn
9th Aug 201912:02 pmRNSPrice Monitoring Extension
31st Jul 20198:34 amRNSHolding(s) in Company
30th Jul 20197:00 amRNSHalf-year Report
11th Jul 20195:08 pmRNSDirector/PDMR Shareholding
29th May 20199:09 amRNSHolding(s) in Company
23rd May 201911:33 amRNSAGM Statement
23rd May 20197:00 amRNSTrading Statement
10th May 20194:49 pmRNSHolding(s) in Company
30th Apr 20194:16 pmRNSDirector/PDMR Shareholding
29th Apr 20194:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20195:04 pmRNSDirector/PDMR Shareholding
18th Apr 201911:18 amRNSNotice of AGM
12th Apr 20198:43 amRNSDirector/PDMR Shareholding
10th Apr 20192:58 pmRNSDirector/PDMR Shareholding
8th Apr 201910:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.